<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Congenital antithrombin III (ATIII) deficiency, although uncommon, is a condition of considerable surgical importance </plain></SENT>
<SENT sid="1" pm="."><plain>Affected patients are at significant risk of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> during a surgical illness and standard forms of prophylaxis may not be effective </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, sequelae of their thromboses may in turn make them a candidate for venous surgery </plain></SENT>
<SENT sid="3" pm="."><plain>An ATIII concentrate is now available in Australia for clinical use </plain></SENT>
<SENT sid="4" pm="."><plain>This report describes two patients who underwent surgery for <z:e sem="disease" ids="C0856587" disease_type="Disease or Syndrome" abbrv="">postphlebitic limbs</z:e> utilizing infusions of ATIII concentrate </plain></SENT>
<SENT sid="5" pm="."><plain>The ATIII deficiency state is reviewed and a method is described that should allow safe surgery in these patients </plain></SENT>
</text></document>